Email alerts New issue alert.
The investigators initiated treatment after being informed of the results of assignment by the data centre. High versus low dosing of oral colchicine for early acute gout flare: Baseline demographics were summarised using SAS V.
Invest Med Int ; Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. The management of acute gouty arthritis will be reviewed here.
Incidence of gout flares during the randomised period. Additionally, alternative agents should be considered, depending upon what has already been tried, and the diagnosis should be reevaluated.
Stepwise dose increase of febuxostat may be an effective alternative to low-dose colchicine prophylaxis during the introduction of urate-lowering therapy. Other analyses were performed using R V. Jiangsu HengRui Medicine Co.
Acute Gout Attack
All topics are updated as new information becomes available. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. The main route of elimination of febuxostat is metabolism in the liver followed by excretion of metabolites in the urine and faeces. Probenecid acts by inhibiting reabsorption of uric acid in the proximal tubules of the kidney. Glucocorticoids are generally tolerated in short-term use for acute attacks in patients in whom NSAIDs or colchicine may pose an increased risk.
Table 2 Incidence of adverse events and adverse reactions by system organ class safety population.
Commonly used strong CYP3A4 inhibitors include human immunodeficiency virus HIV protease inhibitors, clarithromycin and other macrolide antibioticsazole antifungals, and others table 1 [ 42 ]. Anakinra's efficacy is variable in refractory gout: It is metabolized via the uridine diphosphate glucuronosyltransferase system and oxidized by the cytochrome P system. There were no interactions found in our database between colchicine and Uloric. Gout flare was defined as non-steroidal anti-inflammatory drug use for gout symptoms.
Mutual suppression of the uricosuric effects of sulfinpyrazone and salicylate: The corresponding author had full responsibility for the study design, supervised the data collection, had full access to all data, supervised data analysis and was responsible for submitting the manuscript for publication. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: Adherence with urate-lowering therapies among male patients with gout in a routine clinical setting.